We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
-6.1%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.92%
AUM
$41.9B
AUM Growth
-$1.99B
(-4.5%)
Cap. Flow
+$1.51B
Cap. Flow % of AUM
Cap. Flow %
3.59%
Top 10 Holdings %
Top 10 Hldgs %
9.94%
Holding
3,649
New
453
Increased
1,731
Reduced
913
Closed
519
Avg Time Held
1.2
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$237M |
| 2 |
AbbVie
ABBV
|
+$190M |
| 3 |
FedEx
FDX
|
+$149M |
| 4 |
Sysco
SYY
|
+$133M |
| 5 |
Coca-Cola
KO
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$306M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
Union Pacific
UNP
|
+$193M |
| 4 |
Walmart Inc
WMT
|
+$185M |
| 5 |
Alibaba
BABA
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.06% |
| 2 | Technology | 12.3% |
| 3 | Financials | 12.13% |
| 4 | Consumer Staples | 10.53% |
| 5 | Industrials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Colgate-Palmolive
CL
$75B
| $726M | 1.73% |
11,437,700
-1,153,100
| -9% | -$75.3M |
2013 Q2
9 quarters
|
|
2
Novo Nordisk
NVO
$172B
| $714M | 1.7% |
26,342,000
-1,832,000
| -7% | -$51.9M |
2013 Q2
9 quarters
|
|
3
Alaska Air
ALK
$3.84B
| $438M | 1.05% |
5,514,721
-530,479
| -9% | -$40.5M |
2013 Q2
9 quarters
|
|
4
VeriSign
VRSN
$27.1B
| $354M | 0.84% |
5,014,076
-35,300
| -0.7% | -$2.4M |
2013 Q2
9 quarters
|
|
5
Chipotle Mexican Grill
CMG
$34.8B
| $345M | 0.82% |
23,970,000
+8,295,000
| +53% | +$118M |
2013 Q2
9 quarters
|
|
6
Alphabet (Google) Class C
GOOG
$3.88T
| $336M | 0.8% |
10,794,160
+1,429,740
| +15% | +$43.9M |
2014 Q3
4 quarters
|
|
|
SIAL
7
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $330M | 0.79% |
2,374,400
+1,696,468
| +250% | +$237M |
2013 Q2
9 quarters
|
|
8
NetEase
NTES
$75.9B
| $311M | 0.74% |
12,926,500
+609,500
| +5% | +$15.7M |
2013 Q2
9 quarters
|
|
|
LLTC
9
DELISTED
Linear Technology Corp
LLTC
| $309M | 0.74% |
7,662,200
-432,300
| -5% | -$17.7M |
2013 Q2
9 quarters
|
|
10
Domino's
DPZ
$10.3B
| $304M | 0.73% |
2,820,400
-515,784
| -15% | -$57.3M |
2013 Q2
9 quarters
|
|
11
Cboe Global Markets
CBOE
$35.6B
| $283M | 0.68% |
4,223,700
+225,300
| +6% | +$14.2M |
2013 Q2
9 quarters
|
|
12
Allegiant Air
ALGT
$1.85B
| $271M | 0.65% |
1,251,200
+37,300
| +3% | +$7.83M |
2013 Q2
9 quarters
|
|
13
Ryanair
RYAAY
$27.2B
| $261M | 0.62% |
8,137,911
+44,202
| +0.5% | +$1.37M |
2013 Q2
9 quarters
|
|
14
Mastercard
MA
$546B
| $254M | 0.61% |
2,815,600
+430,300
| +18% | +$40.4M |
2013 Q2
9 quarters
|
|
15
Hershey
HSY
$34.1B
| $231M | 0.55% |
2,515,400
-659,200
| -21% | -$60.1M |
2013 Q2
9 quarters
|
|
16
Duke Energy
DUK
$97.4B
| $220M | 0.53% |
3,064,467
+916,100
| +43% | +$66.3M |
2014 Q1
6 quarters
|
|
17
Amgen
AMGN
$237B
| $216M | 0.52% |
1,564,345
-205,900
| -12% | -$32.5M |
2013 Q2
9 quarters
|
|
18
Becton Dickinson
BDX
$54.2B
| $215M | 0.51% |
1,661,542
-213,558
| -11% | -$29.8M |
2013 Q3
8 quarters
|
|
19
Clorox
CLX
$10.4B
| $211M | 0.5% |
1,828,900
+690,200
| +61% | +$77.5M |
2013 Q2
9 quarters
|
|
|
MJN
20
DELISTED
Mead Johnson Nutrition Company
MJN
| $209M | 0.5% |
2,963,300
+855,300
| +41% | +$70.4M |
2013 Q2
9 quarters
|
|
21
Ventas
VTR
$44.5B
| $177M | 0.42% |
3,161,519
+359,540
| +13% | +$23.6M |
2014 Q2
5 quarters
|
|
22
AstraZeneca
AZN
$266B
| $174M | 0.41% |
2,726,450
-1,208,150
| -31% | -$79.5M |
2013 Q2
9 quarters
|
|
23
Sempra
SRE
$55B
| $168M | 0.4% |
3,477,600
+508,800
| +17% | +$25M |
2014 Q3
4 quarters
|
|
|
BCR
24
DELISTED
CR Bard Inc.
BCR
| $166M | 0.4% |
890,900
-66,600
| -7% | -$12.6M |
2013 Q2
9 quarters
|
|
25
Teva Pharmaceutical Industries Limited
TEVA
$46B
| $163M | 0.39% |
2,878,763
+803,000
| +39% | +$52.1M |
2014 Q2
5 quarters
|
|
Similar funds
Jim Simons's Q3 2015 Portfolio in Review
As of Q3 2015, Jim Simons held 3,649 positions worth $41.9B, down 4.5% from $43.9B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Jim Simons deployed $1.51B of net new capital in Q3 2015, opening 453 new positions and adding to 1,731 existing holdings. Its largest new stake was FedEx: 936,400 shares worth $135M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walmart Inc, an estimated $185M trimmed.
- Jim Simons's largest Q3 2015 buy was FedEx: 936,400 shares worth $135M.
- Jim Simons added most to SIGMA - ALDRICH CORP in Q3 2015, an estimated $237M increase.
- Jim Simons's biggest Q3 2015 reduction was Walmart Inc, cutting an estimated $185M.
- Jim Simons fully exited Microsoft in Q3 2015, selling an estimated $306M.
- Jim Simons's ten largest holdings make up 9.9% of its $41.9B portfolio in Q3 2015.
- Jim Simons opened 453 new positions and closed 519 in Q3 2015.
- Jim Simons's portfolio value fell 4.5% quarter-over-quarter to $41.9B.
Based on Renaissance Technologies's 13F filing for Q3 2015, filed 12 Nov 2015.